Jim Wilson, Tachi Yamada, Stephen Squinto

February 3, 2020 10:46 AM EST

How much does it cost to bootstrap a gene therapy startup? Not too much if you're Jim Wilson, per Passage Bio's $125M IPO filing

Amber Tong

Days ago when Deerfield partner Bruce Goldsmith jumped to helm Passage Bio, he cited a few reasons why it’s an “extremely exciting time” to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

The ‘MAHA report’: Four key takeaways on vaccines, medicine and the pharma industry

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

FDA chief to senators: 3,000+ staff departures won't delay user fee targets

House passes Trump tax bill with PBM and orphan drug reforms included

Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?